Cargando…

SASLT Position Statement on the Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection

Detalles Bibliográficos
Autores principales:	Alghamdi, Abdullah S., Alqutub, Adel, Abaalkhail, Faisal, Sanai, Faisal M., Alghamdi, Hamdan, Altraif, Ibrahim, Alswat, Khalid A., Alghamdi, Mohammed Y., Babatin, Mohammed A., Alfaleh, Faleh Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Special Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392576/ https://www.ncbi.nlm.nih.gov/pubmed/25843190 http://dx.doi.org/10.4103/1319-3767.153810

Ejemplares similares

SASLT Guidelines: Update in Treatment of Hepatitis C Virus Infection
por: Alghamdi, Abdullah S., et al.
Publicado: (2016)

SASLT Practice Guidelines: Management of Hepatitis C Virus Infection
por: Alghamdi, Abdullah S., et al.
Publicado: (2012)

SASLT Practice Guidelines for the Management of Hepatitis C Virus Infection: Summary of Recommendations
por: Alghamdi, Abdullah S., et al.
Publicado: (2012)

SASLT practice guidelines for the management of Hepatitis B virus – An update
por: Abaalkhail, Faisal A., et al.
Publicado: (2021)

SASLT Practice Guidelines for the Management of Hepatitis B Virus
por: Abaalkhail, Faisal, et al.
Publicado: (2014)

Epidemiology, Disease Burden, and Treatment Strategies of Chronic Hepatitis C Virus Infections in Saudi Arabia in the New Treatment Paradigm Shift
por: Aljumah, Abdulrahman A., et al.
Publicado: (2016)

Saudi Association for the Study of Liver Diseases and Transplantation position statement on liver transplantation during the COVID-19 pandemic
por: Al-Judaibi, Bandar, et al.
Publicado: (2020)

Greater prevalence of comorbidities with increasing age: Cross-sectional analysis of chronic hepatitis B patients in Saudi Arabia
por: Sanai, Faisal M., et al.
Publicado: (2019)

Hepatitis C Position Statement: Taking a Stand and Standing by it
por: Sanai, Faisal M., et al.
Publicado: (2015)

Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry
por: Alswat, Khalid, et al.
Publicado: (2021)

Saudi Association for the Study of Liver diseases and Transplantation position statement on the hepatology workforce in Saudi Arabia
por: Al-Judaibi, Bandar, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease burden – Saudi Arabia and United Arab Emirates, 2017–2030
por: Alswat, Khalid, et al.
Publicado: (2018)

Cholestatic liver disease: Practice guidelines from the Saudi Association for the Study of Liver diseases and Transplantation
por: Mawardi, Mohammad, et al.
Publicado: (2021)

Revealing Hepatitis B Virus as a Silent Killer: A Call-to-Action for Saudi Arabia
por: Alghamdi, Mohammed, et al.
Publicado: (2021)

Treatment efficacy of ledipasvir/sofosbuvir for 8 weeks in non-cirrhotic chronic hepatitis C genotype 4 patients
por: Babatin, Mohammed A., et al.
Publicado: (2019)

Use of COVID-19 vaccines in patients with liver disease and post-liver transplantation: Position statement of the Saudi association for the study of liver diseases and transplantation
por: Alqahtani, Saleh A., et al.
Publicado: (2021)

Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B
por: Sanai, Faisal M., et al.
Publicado: (2017)

Lower prevalence of hepatic fibrosis in low viremic hepatitis B patients with fluctuating HBV DNA levels
por: Sanai, Faisal M., et al.
Publicado: (2022)

Hepatitis B care pathway in Saudi Arabia: Current situation, gaps and actions
por: Aljumah, Abdulrahman A., et al.
Publicado: (2019)

Correlation Between Hepatitis B Surface Antigen Titers and HBV DNA Levels
por: Alghamdi, Amal, et al.
Publicado: (2013)

Saudi Arabian Consensus Statement on Vagus Nerve Stimulation for Refractory Epilepsy
por: Alqadi, Khalid, et al.
Publicado: (2021)

Clinical Characteristics of Hepatitis B Virus Patients After Switching to Tenofovir Alafenamide Fumarate: A Retrospective Observational Study
por: Alghamdi, Abdullah S, et al.
Publicado: (2020)

Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation
por: Alqahtani, Saleh A., et al.
Publicado: (2020)

Infection Control Practices at the Dental Clinics in Jeddah, Saudi Arabia
por: Natto, Zuhair S, et al.
Publicado: (2021)

Impact of Drug Use Policy on the Appropriate Use of Direct Acting Antiviral Agents for Hepatitis C in Saudi Arabia
por: Alotaibi, Ahmed Saqer, et al.
Publicado: (2021)

Cyberknife Radiosurgery for the Treatment of Head and Neck Cancer: A Systematic Review
por: Soman, Cristalle, et al.
Publicado: (2021)

Risk Factors of Arm Lymphedema Following Breast Reconstruction – An Updated Meta-Analysis
por: Alghamdi, Abdulrahman, et al.
Publicado: (2023)

Assessment of the Sterility of New Endodontic Files Received From the Manufacturer Using Microbial Culture and Scanning Electron Microscopic Analysis: An In Vitro Study
por: Merdad, Khalid A, et al.
Publicado: (2022)

Effect of neat and binary vehicle systems on the solubility and cutaneous delivery of piperine
por: Alomrani, Abdullah Hasan, et al.
Publicado: (2018)

Impact of Ramadan on Physical Activity and Sleeping Patterns in Individuals with Type 2 Diabetes: The First Study Using Fitbit Device
por: Alghamdi, Abdullah S., et al.
Publicado: (2020)

Clinicopathologic characteristics and outcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection
por: Aljumah, Abdulrahman A., et al.
Publicado: (2018)

Knowledge and Attitude of Dentists Towards Obstructive Sleep Apnea
por: Alzahrani, Manar Mohammed, et al.
Publicado: (2021)

Hepatic fibrosis changes in patients with chronic hepatitis C infection who respond to direct-acting antivirals
por: Alswat, Khalid, et al.
Publicado: (2022)

A Liraglutide Injection Superimposing a Starvation Acidosis: a Case Report
por: Alghamdi, Mohannad, et al.
Publicado: (2022)

Favorable response to carbamazepine therapy in genetically proven myoclonus-dystonia child
por: Aljabri, Mohammed F., et al.
Publicado: (2021)

Sa1390: THE EFFICACY OF ELBASVIR/GRAZOPREVIR FIXED-DOSE COMBINATION FOR 8 WEEKS IN HCV TREATMENT AND HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN TREATMENT-NAIVE, NON-CIRRHOTIC, GENOTYPE 4-INFECTED PATIENTS (ELEGANT-4)
por: AlEid, Ahmad, et al.
Publicado: (2022)

Expression of Concern: A Giant Porencephaly: A Rare Etiology of Pediatric Seizures
por: Alzahrani, Rayan A, et al.
Publicado: (2022)

A Giant Porencephaly: A Rare Etiology of Pediatric Seizures
por: Alzahrani, Rayan A, et al.
Publicado: (2021)

Risk of Neuropsychiatric Adverse Effects of Lipid-Lowering Drugs: A Mendelian Randomization Study
por: Alghamdi, Jahad, et al.
Publicado: (2018)

Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): protocol for a prospective cohort study of high-risk patients for HCC using GALAD-score
por: Truong, Thai Ngoc, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gngu5p63mhf01lt5ibo5jpm227